UO > About > Organizational Structure > Faculties & Institutes > Faculty of Medicine

Tomáš Jelínek


Academic degree, name, surname:MUDr. Tomáš Jelínek, Ph.D.
Room, floor, building:
Position:
Research interests and teaching:
Department (Faculty): Department of Clinic Subjects (Faculty of Medicine)
Phone number, mobile: +420 597 374 587
E-mail:
Personal website:



No record found.



A Bird's-Eye View of Cell Sources for Cell-Based Therapies in Blood Cancers
Benjamin Motais, Sandra Charvátová, Matouš Hrdinka, Michal Šimíček, Tomáš Jelínek, Tereza Ševčíková, Zdeněk Kořístek, Roman Hájek, Julio Rodriguez Bago ... other authors
Year: 2020, CANCERS
journal article

Bortezomib Retreatment Is Effective in Relapsed Multiple Myeloma Patients - Real-Life Clinical Practice Data
M. Stork, S. Ševčíková, L. Brožová, I. Špička, V. Maisnar, J. Minařík, A. Jungová, E. Gregora, R. Velichová, Roman Hájek, Tomáš Jelínek, L. Pour ... other authors
Year: 2020, Neoplasma
journal article

Dynamics of tumor-specific cfDNA in response to therapy in multiple myeloma patients
David Vrabel, Lenka Sedlaříková, Lenka Besse, Lucie Říhová, Renata Bezděková, Martina Almasi, Veronika Kubaczková, Lucie Brožová, Jiří Jarkovský, Hana Plonková, Tomáš Jelínek, Viera Sandecká, Martin Stork, Luděk Pour, Sabina Ševčíková, Roman Hájek ... other authors
Year: 2020, European Journal of Haematology
journal article

Identifying and treating candidates for checkpoint inhibitor therapies in multiple myeloma and lymphoma
Katarina Hradská, Michal Kaščák, Roman Hájek, Tomáš Jelínek
Year: 2020, Expert Review of Hematology
journal article

Intercellular Mitochondrial Transfer in the Tumor Microenvironment
Hana Šahinbegović, Tomáš Jelínek, Matouš Hrdinka, Julio Rodriguez Bago, Marcello Turi, Tereza Ševčíková, Amina Kurtovic-Kotaric, Roman Hájek, Michal Šimíček ... other authors
Year: 2020, Cancers
journal article

Monoclonal antibodies in the treatment of AL amyloidosis: co-targetting the plasma cell clone and amyloid deposits
Tereza Popková, Roman Hájek, Tomáš Jelínek
Year: 2020, BRITISH JOURNAL OF HAEMATOLOGY
journal article

Real-world effectiveness and safety of ixazomib-lenalidomide-dexamethasone in relapsed/refractory multiple myeloma
E. Terpos, K. Ramasamy, N. Maouche, J. Minařík, I. Ntanasis-Stathopoulos, E. Katodritou, W. M. Jenner, H. Plonková, M. Kotsoupolou, J. Kothari, Tomáš Jelínek, A. M. Dimopoulos, A. Zomas, Roman Hájek ... other authors
Year: 2020, ANNALS OF HEMATOLOGY
journal article

Transcriptional profiling of circulating tumor cells in multiple myeloma: a new model to understand disease dissemination
J.J. Garces, Michal Šimíček, M. Vicari, L. Brožová, L. Burgos, R. Bezděková, A. Diego, M.J. Calasanz, Kateřina Growková, Alexander Vdovin, Tomáš Jelínek, Roman Hájek ... other authors
Year: 2020, LEUKEMIA
journal article

Venetoclax plus bortezomib and dexamethasone in heavily pretreated end-stage myeloma patients without t(11;14): A real-world cohort
Tomáš Jelínek, Tereza Popková, Juraj Ďuraš, Jana Fečková Mihályová, Kateřina Benková, Lucie Černá, Zdeněk Kořístek, Michal Šimíček, Roman Hájek ... other authors
Year: 2020, HEMATOLOGICAL ONCOLOGY
journal article

Venetoclax: the first anti-myeloma agent with a reliable biomarker
Tomáš Jelínek
Year: 2020, BRITISH JOURNAL OF HAEMATOLOGY
journal article

Cytarabine plus G-CSF is more effective than cyclophosphamide plus G-CSF as a stem cell mobilization regimen in multiple myeloma
Roman Hájek, Tomáš Jelínek, Lucie Adamusová, Tereza Popková, Jana Smejkalová, Michal Šimíček, Dana Salounová, Michal Kaščák, Jana Mihalyová, Hana Plonková, Juraj Ďuraš, Milan Navrátil, Zdeněk Kořístek ... other authors
Year: 2019, BONE MARROW TRANSPL
journal article

Extramedullary disease in multiple myeloma - controversies and future directions
Roman Hájek, Sabina Ševčíková, Jiří Minařík, Martin Stork, Tomáš Jelínek, Luděk Pour ... other authors
Year: 2019, BLOOD REV
journal article

Lenalidomide and dexamethasone in treatment of patients with relapsed and refractory multiple myeloma - analysis of data from the Czech Myeloma Group Registry of Monoclonal Gammopathies
Roman Hájek, V. Maisnar, Z. Stefanikova, I. Spicka, L. Pour, J. Minařík, M. Flochová, J. Radocha, E. Gregora, N. Stecová, Tomáš Jelínek, A. Jungová, E. Kralíková, L. Brožová ... other authors
Year: 2019, NEOPLASMA
journal article

Simplified novel prognostic score for real-life older adults with multiple myelomaregistry-based analysis
Roman Hájek, J. Radocha, L. Brožová, L. Pour, I. Spicka, J. Minařík, E. Gregorová, A. Jungová, Tomáš Jelínek, A. Heindorfer, M. Sykora, V. Maisnar ... other authors
Year: 2019, ANN HEMATOL
journal article

Single agent daratumumab in advanced multiple myeloma possesses significant efficacy even in an unselected 'real-world' population
Roman Hájek, Jiří Minařík, Luděk Pour, Vladimír Maisnar, Ivan Špička, Alexandra Jungová, Tomáš Jelínek, Lucie Brožová, Petra Krhovská, Vlastimil Scudla ... other authors
Year: 2019, BIOMEDICAL PAPERS-OLOMOUC
journal article

Single-agent venetoclax induces MRD-negative response in relapsed primary plasma cell leukemia with t(11;14)
Roman Hájek, Tomáš Jelínek, Jana Fečková Mihályová, Juraj Ďuraš, Tereza Popková, Kateřina Benková, Hana Plonková, Jana Zuchnická, Lucie Broskevičová, Lucie Huvarová, Lucie Černá, Kateřina Growková, Michal Šimíček, Martin Havel, Jaromír Gumulec, Zdeněk Kořístek, Bruno Paiva, Petra Richterová, Milan Navrátil, Michal Kascák ... other authors
Year: 2019, AMERICAN JOURNAL OF HEMATOLOGY
journal article

Adjusted comparison of daratumumab monotherapy versus real-world historical control data from the Czech Republic in heavily pretreated and highly refractory multiple myeloma patients
Tomáš Jelínek, Roman Hájek, V. Maisnar, L. Pour, I. Špička, J. Minařík, E. Gregora, P. Kessler, M. Sýkora, H. Fraňková, D. Adamová, M. Wróbel, P. Mikula, J. Jarkovský, J. Diels, X. Gatopoulou, H Besson, L. Brožová, T. lto, Š. Veselá ... other authors
Year: 2018, Current Medical Research and Opinion
journal article

CD38 cílená léčba u mnohočetného myelomu
Tomáš Jelínek, Jana Fečková Mihályová, Roman Hájek
Year: 2018, Vnitřní lékařství
journal article

Newly designed 11-gene panel reveals first case of hereditary amyloidosis captured by massive parallel sequencing
Zuzana Kufová, Tereza Ševčíková, J. Januska, P. Vojta, A. Boday, P. Vanickova, Jana Filipová, Kateřina Growková, Tomáš Jelínek, M. Hajduch, Roman Hájek ... other authors
Year: 2018, JOURNAL OF CLINICAL PATHOLOGY
journal article

Risk Factors Associated with Development of Extramedullary Disease in Multiple Myeloma
Tomáš Jelínek
Year: 2018
abstract in proceedings

Transcriptomic Profiling of Circulating Tumor Cells (CTCs) in Multiple Myeloma (MM): A New Model to Understand Disease Dissemination
Tomáš Jelínek
Year: 2018
abstract in proceedings

Update on PD-1/PD-L1 Inhibitors in Multiple Myeloma
Tomáš Jelínek, Roman Hájek, B. Paiva
Year: 2018, Frontiers in Immunology
journal article

Venetoclax: A new wave in hematooncology
Jana Fečková Mihályová, Tomáš Jelínek, K. Growková, Matouš Hrdinka, Michal Šimíček, Roman Hájek ... other authors
Year: 2018, EXPERIMENTAL HEMATOLOGY
journal article

Biobanking strategy and sample preprocessing for integrative research in monoclonal gammopathies
Tereza Ševčíková, Kateřina Growková, Zuzana Kufová, Jana Filipová, P. Vrublová, Tomáš Jelínek, Zdeněk Kořístek, Fedor Kryukov, Elena Kryukova, Roman Hájek ... other authors
Year: 2017, JOURNAL OF CLINICAL PATHOLOGY
journal article

Current applications of multiparameter flow cytometry in plasma cell disorders
Tomáš Jelínek, R. Bezdekova, R. Zatopkova, L. Burgos, Michal Šimíček, Tereza Ševčíková, B. Paiva, Roman Hájek ... other authors
Year: 2017, BLOOD CANCER JOURNAL
journal article

Daratumumab - Naděje pro myelomové pacienty, výzva pro klinické laboratoře
Tomáš Jelínek, Martin Kořístka, Zuzana Čermáková, Roman Hájek
Year: 2017, Klinicka Onkologie
journal article

Diagnostic Tools of Waldenström's Macroglobulinemia - Best Possibilities for Non-invasive and Long-term Disease Monitoring
Kateřina Growková, Zuzana Kufová, Tereza Ševčíková, Jana Filipová, M. Kascak, Tomáš Jelínek, S. Grosicki, A. Barchnicka, L. Roziakova, M. Mistrik, M. Simicek, Roman Hájek ... other authors
Year: 2017, Klinická onkologie
journal article

PD-1/PD-L1 inhibitors in haematological malignancies
Tomáš Jelínek, J. Mihalyova, M. Kascak, J. Duras, Roman Hájek
Year: 2017, IMMUNOLOGY
journal article

PD-1/PD-L1 inhibitors in haematological malignancies: update 2017
Tomáš Jelínek, Roman Hájek, J. Mihalyova, M. Kascak, J. Duras
Year: 2017, Immunology
journal article

PD-1/PD-L1 inhibitors in multiple myeloma: The present and the future
Tomáš Jelínek, Roman Hájek
Year: 2017, ONCOIMMUNOLOGY
journal article

Proteasome inhibitors in AL amyloidosis: focus on mechanismof action and clinical activity
Tomáš Jelínek, Elena Kryukova, Zuzana Kufová, Fedor Kryukov, Roman Hájek
Year: 2017, Hematological Oncology
journal article

Současný algoritmus léčby nemocných s mnohočetným myelomem - kam kráčí?
Roman Hájek, Tomáš Jelínek
Year: 2017, Acta medicinae
journal article

Whole exome sequencing of aberrant plasma cells in a patient with multiple myeloma minimal residual disease
M. Zatopkova, Jana Filipová, Tomáš Jelínek, Tereza Ševčíková, Michal Šimíček, L. Rihova, R. Bezdekova, Kateřina Growková, Zuzana Kufová, J. Smejkalova, M. Hajduch, L. Pour, J. Minarik, A. Jungova, V. Maisnar, Fedor Kryukov, Roman Hájek ... other authors
Year: 2017, Klinicka Onkologie
journal article

Immunomodulatory drugs in AL amyloidosis
Tomáš Jelínek, Zuzana Kufová, Roman Hájek
Year: 2016, CRIT REV ONCOL HEMAT
journal article

Monoclonal antibodies - A new era in the treatment of multiple myeloma.
Tomáš Jelínek, Roman Hájek
Year: 2016, Blood reviews
journal article

No record found.

View more records

View more records

View more records

View more records

View more records

View more records

View more records

View more records



No record found.



No record found.

rss
social hub